BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23869784)

  • 1. Cytochrome p450 for cancer prevention and therapy.
    Chen TC
    Anticancer Agents Med Chem; 2014 Jan; 14(1):52-3. PubMed ID: 23869784
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytochrome P450 enzymes: novel options for cancer therapeutics.
    McFadyen MC; Melvin WT; Murray GI
    Mol Cancer Ther; 2004 Mar; 3(3):363-71. PubMed ID: 15026557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition and inactivation of human CYP2J2: Implications in cardiac pathophysiology and opportunities in cancer therapy.
    Karkhanis A; Hong Y; Chan ECY
    Biochem Pharmacol; 2017 Jul; 135():12-21. PubMed ID: 28237650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal adhesion kinase.
    Prudhomme M
    Anticancer Agents Med Chem; 2014 Jan; 14(1):1. PubMed ID: 24410578
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.
    Bruno RD; Njar VC
    Bioorg Med Chem; 2007 Aug; 15(15):5047-60. PubMed ID: 17544277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brussels sprouts: an exceptionally rich source of ambiguity for anticancer strategies.
    Paolini M
    Toxicol Appl Pharmacol; 1998 Oct; 152(2):293-4. PubMed ID: 9852997
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cancer chemotherapy and drug metabolism enzyme].
    Xu F; Zhen YS; Shao RG
    Sheng Li Ke Xue Jin Zhan; 2005 Oct; 36(4):295-8. PubMed ID: 16408765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.
    van Schaik RH
    Invest New Drugs; 2005 Dec; 23(6):513-22. PubMed ID: 16267627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cytochrome P450 in tumor tissues and its association with cancer development.
    Oyama T; Kagawa N; Kunugita N; Kitagawa K; Ogawa M; Yamaguchi T; Suzuki R; Kinaga T; Yashima Y; Ozaki S; Isse T; Kim YD; Kim H; Kawamoto T
    Front Biosci; 2004 May; 9():1967-76. PubMed ID: 14977602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting cytochrome P450-dependent cancer cell mitochondria: cancer associated CYPs and where to find them.
    Guo Z; Johnson V; Barrera J; Porras M; Hinojosa D; Hernández I; McGarrah P; Potter DA
    Cancer Metastasis Rev; 2018 Sep; 37(2-3):409-423. PubMed ID: 30066055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochromes P450 and cancer.
    Kaminsky LS; Spivack SD
    Mol Aspects Med; 1999; 20(1-2):70-84, 137. PubMed ID: 10575653
    [No Abstract]   [Full Text] [Related]  

  • 12. Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases.
    Njar VC; Gediya L; Purushottamachar P; Chopra P; Vasaitis TS; Khandelwal A; Mehta J; Huynh C; Belosay A; Patel J
    Bioorg Med Chem; 2006 Jul; 14(13):4323-40. PubMed ID: 16530416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytochrome P450s and cancer].
    Lu H; Li Y
    Sheng Li Ke Xue Jin Zhan; 1997 Apr; 28(2):178-80. PubMed ID: 11038721
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacogenetics and cancer chemotherapy.
    Iyer L; Ratain MJ
    Eur J Cancer; 1998 Sep; 34(10):1493-9. PubMed ID: 9893619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Cancer Drug Fraction of Metabolism Database.
    Hua L; Chiang CW; Cong W; Li J; Wang X; Cheng L; Feng W; Quinney SK; Wang L; Li L
    CPT Pharmacometrics Syst Pharmacol; 2019 Jul; 8(7):511-519. PubMed ID: 31206254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome p450 retinoic acid 4-hydroxylase inhibitors: potential agents for cancer therapy.
    Njar VC
    Mini Rev Med Chem; 2002 Jun; 2(3):261-9. PubMed ID: 12370067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-trans-retinoic acid modulation of drug-metabolizing enzyme activities: investigation with selective metabolic drug probes.
    Adedoyin A; Stiff DD; Smith DC; Romkes M; Bahnson RC; Day R; Hofacker J; Branch RA; Trump DL
    Cancer Chemother Pharmacol; 1998; 41(2):133-9. PubMed ID: 9443626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cytochrome P450 phenotyping in cancer treatment.
    Dees EC; Watkins PB
    J Clin Oncol; 2005 Feb; 23(6):1053-5. PubMed ID: 15657406
    [No Abstract]   [Full Text] [Related]  

  • 19. [Role of cytochrome P450 enzymes in the metabolism of antineoplastic drugs].
    Quiñones S L; Rosero P M; Roco A A; Moreno T I; Sasso A J; Varela F N; Cáceres L D; Saavedra S I
    Rev Med Chil; 2008 Oct; 136(10):1327-35. PubMed ID: 19194632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P450 enzyme expression patterns in the NCI human tumor cell line panel.
    Yu LJ; Matias J; Scudiero DA; Hite KM; Monks A; Sausville EA; Waxman DJ
    Drug Metab Dispos; 2001 Mar; 29(3):304-12. PubMed ID: 11181500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.